Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 139.5 GBX -0.71% Market Closed
Market Cap: 118.4m GBX

Wall Street
Price Targets

DXRX Price Targets Summary
Diaceutics PLC

Wall Street analysts forecast DXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXRX is 204 GBX with a low forecast of 181.8 GBX and a high forecast of 236.25 GBX.

Lowest
Price Target
181.8 GBX
30% Upside
Average
Price Target
204 GBX
46% Upside
Highest
Price Target
236.25 GBX
69% Upside
Diaceutics PLC Competitors:
Price Targets
WAT
Waters Corp
1% Upside
DIVISLAB
Divi's Laboratories Ltd
7% Upside
TECH
Bio-Techne Corp
16% Upside
NANOFH
Nanoform Finland Oyj
192% Upside
300463
Maccura Biotechnology Co Ltd
34% Upside
688238
Obio Technology Shanghai Corp Ltd
50% Upside
ANTHEM
Anthem Biosciences Ltd
21% Upside
WST
West Pharmaceutical Services Inc
31% Upside

Revenue
Forecast

Revenue Estimate
Diaceutics PLC

For the last 7 years the compound annual growth rate for Diaceutics PLC's revenue is 23%. The projected CAGR for the next 3 years is 23%.

23%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXRX's stock price target?
Price Target
204 GBX

According to Wall Street analysts, the average 1-year price target for DXRX is 204 GBX with a low forecast of 181.8 GBX and a high forecast of 236.25 GBX.

What is Diaceutics PLC's Revenue forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Diaceutics PLC's revenue is 23%. The projected CAGR for the next 3 years is 23%.

Back to Top